Febrile urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and-nonproducing bacteria: A comparative study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, D.H. | - |
dc.contributor.author | Kim, K.W. | - |
dc.contributor.author | Cho, H.-K. | - |
dc.contributor.author | Tchah, H. | - |
dc.contributor.author | Jeon, I.S. | - |
dc.contributor.author | Ryoo, E. | - |
dc.contributor.author | Sun, Y.H. | - |
dc.date.available | 2020-02-28T10:46:30Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2384-1079 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/11014 | - |
dc.description.abstract | Purpose: The purpose of this study was to investigate the clinical characteristics and outcome of febrile urinary tract infections (UTIs) caused by community-acquired extended-spectrum β-lactamase (CA-ESBL)-producing and -nonproducing bacteria. Methods: We analyzed febrile UTIs in children hospitalized at Gachon University Gil Medical Center from January 2011 to December 2013 through retrospective data collection from their medical records. Results: Among pathogens causing 374 episodes of UTIs, the proportion of ESBL-producing bacteria was 13.1% (49/374). The proportion of ESBL-producing Escherichia coli and Klebsiella spp. was 13.6% (48/354) and 5.0% (1/20), respectively. There was no significant difference between the CA-ESBL and CA non-ESBL groups in duration of fever (4.2±2.7 vs.3.7±2.1 days, P =0.10) and bacterial eradication rate with empirical antibiotics (100% vs. 100%). The risk of cortical defects on renal scan significantly depended on existence of vesicoureteral reflux rather than ESBL production of pathogen. Conclusions: There was no significant difference between the CA-ESBL and CA non-ESBL groups in renal cortical defects and clinical outcome. Careful choice of antibiotics is important for treatment of community-acquired UTI in children. © 2015, Korean Society of Pediatric Infectious Diseases. All rights reserved. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | Korean Society of Pediatric Infectious Diseases | - |
dc.relation.isPartOf | Pediatric Infection and Vaccine | - |
dc.subject | antibiotic agent | - |
dc.subject | antibiotic therapy | - |
dc.subject | Article | - |
dc.subject | bacterial clearance | - |
dc.subject | bacterial load | - |
dc.subject | child | - |
dc.subject | community acquired infection | - |
dc.subject | controlled study | - |
dc.subject | disease duration | - |
dc.subject | eradication therapy | - |
dc.subject | extended spectrum beta lactamase producing Escherichia coli | - |
dc.subject | extended spectrum beta lactamase producing Klebsiella pneumoniae | - |
dc.subject | fever | - |
dc.subject | human | - |
dc.subject | kidney injury | - |
dc.subject | kidney scintiscanning | - |
dc.subject | medical record review | - |
dc.subject | pediatric hospital | - |
dc.subject | retrospective study | - |
dc.subject | university hospital | - |
dc.subject | urinary tract infection | - |
dc.subject | vesicoureteral reflux | - |
dc.title | Febrile urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and-nonproducing bacteria: A comparative study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.doi | 10.14776/piv.2015.22.1.29 | - |
dc.identifier.bibliographicCitation | Pediatric Infection and Vaccine, v.22, no.1, pp.29 - 35 | - |
dc.identifier.kciid | ART001983177 | - |
dc.identifier.scopusid | 2-s2.0-84938587268 | - |
dc.citation.endPage | 35 | - |
dc.citation.startPage | 29 | - |
dc.citation.title | Pediatric Infection and Vaccine | - |
dc.citation.volume | 22 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Ahn, D.H. | - |
dc.contributor.affiliatedAuthor | Kim, K.W. | - |
dc.contributor.affiliatedAuthor | Cho, H.-K. | - |
dc.contributor.affiliatedAuthor | Tchah, H. | - |
dc.contributor.affiliatedAuthor | Jeon, I.S. | - |
dc.contributor.affiliatedAuthor | Ryoo, E. | - |
dc.contributor.affiliatedAuthor | Sun, Y.H. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Extended-spectrum β-lactamase | - |
dc.subject.keywordAuthor | Urinary tract infection | - |
dc.subject.keywordPlus | antibiotic agent | - |
dc.subject.keywordPlus | antibiotic therapy | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | bacterial clearance | - |
dc.subject.keywordPlus | bacterial load | - |
dc.subject.keywordPlus | child | - |
dc.subject.keywordPlus | community acquired infection | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | disease duration | - |
dc.subject.keywordPlus | eradication therapy | - |
dc.subject.keywordPlus | extended spectrum beta lactamase producing Escherichia coli | - |
dc.subject.keywordPlus | extended spectrum beta lactamase producing Klebsiella pneumoniae | - |
dc.subject.keywordPlus | fever | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | kidney injury | - |
dc.subject.keywordPlus | kidney scintiscanning | - |
dc.subject.keywordPlus | medical record review | - |
dc.subject.keywordPlus | pediatric hospital | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | university hospital | - |
dc.subject.keywordPlus | urinary tract infection | - |
dc.subject.keywordPlus | vesicoureteral reflux | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.